Form 4: Director Jennifer McPeek Adjusts Cushman & Wakefield Stake

Director Jennifer McPeek acquired 14,041 restricted stock units and converted 17,013 units into common shares of Cushman & Wakefield.

Summary

• Director Jennifer McPeek received a grant of 14,041 restricted stock units (RSUs) on May 14, 2026.
• The director converted 17,013 previously awarded RSUs into an equal number of common shares on May 15, 2026.
• Following these transactions, the director holds 35,516 common shares directly.
• The new RSU grant is scheduled to vest and settle on May 14, 2027, contingent upon continued board service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director equity compensation.

Positives

• Director maintains a direct equity stake of 35,516 shares, aligning interests with shareholders.
• The transaction reflects standard equity compensation vesting and new grant cycles for board members.

Negatives

• None identified; this is a routine disclosure of director compensation.

Risks

• Vesting of the new 14,041 RSU grant is subject to the director's continued service on the board through May 14, 2027.

Future Outlook

The director's new RSU grant is expected to vest on May 14, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance and director compensation practices within the commercial real estate services sector, where equity-based incentives are common for board retention.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices at peer firms like CBRE Group and JLL.

Stakeholder Impact

• Shareholders may view the director's continued equity ownership as a positive sign of commitment to the company's long-term performance.

Next Steps

• Vesting of 14,041 RSUs on May 14, 2027.

Key Dates

Keywords

Cushman & Wakefield, CWK, Form 4, Insider Trading, Director Compensation, Restricted Stock Units